9TN-24853-08685
2 vaccinations
4 coded responses
25 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 532 / WI
- Registered
- 2022-07-01
- Relationship
- Child or adolescent in my care
- Guardian
- GLQ-30124-93645
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-30
Dose 1 — Moderna
-
2022-07-01
Registered in v-safe
-
2022-07-01
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Redness · NoneUnder 3 check-in
- 2022-07-02
- 2022-07-03
- 2022-07-04
- 2022-07-05
- 2022-07-06
- 2022-07-07
-
2022-07-14
Survey response — day 14, dose 1, under 3MedDRA: Injection site erythema, Injection site induration, Injection site pain — Feeling: GoodFree text: Developed an indurated erythematous ring around vaccine site on day 8 post-vaccine. Lasted 4 days and resolved on its own. She had mild tenderness at the site.MedDRA releases: 2024-11 · check-in free text available
- 2022-07-21
-
2022-07-28
Survey response — day 28, dose 1, under 3MedDRA: Cough, Fatigue, Pyrexia, Vomiting — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fever, cough, fatigue, vomitingMedDRA releases: 2024-11 · check-in free text available
- 2022-08-04
- 2022-08-11
-
2022-11-01
Dose 2 — ModernaCo-administered: Flu
-
2022-11-02
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Site: Pain · NoneUnder 3 check-in
- 2022-11-03
- 2022-11-04
- 2022-11-05
- 2022-11-06
- 2022-11-07
- 2022-11-08
- 2022-11-15
-
2022-11-29
Survey response — day 28, dose 2, under 3MedDRA: Pyrexia, Viral infection — Feeling: Good · Be unable to work or attend schoolFree text: Viral infection with feverMedDRA releases: 2024-11 · check-in free text available
-
2022-12-06
Survey response — day 35, dose 2, under 3MedDRA: Croup infectious — Feeling: Poor · Be unable to work or attend schoolFree text: CroupMedDRA releases: 2024-11 · check-in free text available
- 2022-12-17
- 2023-02-02
- 2023-05-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-30 | Moderna | No |
| 2 | 2022-11-01 | Moderna | Flu |
Free text
Release 12 (Under 3) — day 14, dose 1, under 3
Symptoms: Developed an indurated erythematous ring around vaccine site on day 8 post-vaccine. Lasted 4 days and resolved on its own. She had mild tenderness at the site.
Release 12 (Under 3) — day 28, dose 1, under 3
Symptoms: Fever, cough, fatigue, vomiting
Release 12 (Under 3) — day 28, dose 2, under 3
Symptoms: Viral infection with fever
Release 12 (Under 3) — day 35, dose 2, under 3
Symptoms: Croup
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Croup infectious | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Injection site erythema | · | · | ✓ |
| SD | Injection site induration | · | · | ✓ |
| SD | Injection site pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release